Telomere length and age-dependent telomere attrition: the blood-and-muscle model


Journal

Canadian journal of physiology and pharmacology
ISSN: 1205-7541
Titre abrégé: Can J Physiol Pharmacol
Pays: Canada
ID NLM: 0372712

Informations de publication

Date de publication:
Apr 2019
Historique:
pubmed: 16 3 2019
medline: 17 7 2019
entrez: 16 3 2019
Statut: ppublish

Résumé

Short telomere length (TL) is associated with atherosclerotic cardiovascular disease (ACVD) and other age-related diseases. It is unclear whether these associations originate from having inherently short TL or a faster TL attrition before or during disease development. We proposed the blood-and-muscle model to assess TL dynamics throughout life course. Our objective was to measure TL in leukocytes (LTL) and in skeletal muscle (MTL), which served as a proxy of TL at birth. The delta (MTL-LTL) represented life-long telomere attrition. Blood draws and skeletal muscle biopsies were performed on 35 Lebanese individuals undergoing surgery. Following DNA extraction, LTL and MTL were measured by Southern blot. In every individual aged between 30 and 85 years, MTL was longer than LTL. With age, MTL and LTL decreased, but the delta (MTL-LTL) increased by 14 bp/year. We validated the blood-and-muscle model that allowed us to identify TL, TL at birth, and lifelong TL attrition in a cross-sectional study. This model can be used in larger cross-sectional studies to evaluate the association of telomere dynamics with age-related diseases onset and progression.

Identifiants

pubmed: 30874445
doi: 10.1139/cjpp-2018-0582
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

328-334

Auteurs

Mirna N Chahine (MN)

a Foundation-Medical Research Institutes, Beirut, Lebanon.
b Faculty of Medical Sciences, Lebanese University, Hadath, Lebanon.

Simon Toupance (S)

c Université de Lorraine, Inserm, DCAC, F-54000 Nancy, France.
d Université de Lorraine, CHRU-Nancy, Pôle "Maladies du Vieillissement, Gérontologie et Soins Palliatifs", F-54000, France.
e Nancyclotep-GIE, F-54000 Nancy, France.

Sandy El-Hakim (S)

f Faculty of Public Health II, Lebanese University, Fanar, Lebanon.

Carlos Labat (C)

c Université de Lorraine, Inserm, DCAC, F-54000 Nancy, France.

Sylvie Gautier (S)

d Université de Lorraine, CHRU-Nancy, Pôle "Maladies du Vieillissement, Gérontologie et Soins Palliatifs", F-54000, France.

Toufic Moussallem (T)

b Faculty of Medical Sciences, Lebanese University, Hadath, Lebanon.

Pierre Yared (P)

b Faculty of Medical Sciences, Lebanese University, Hadath, Lebanon.

Roland Asmar (R)

a Foundation-Medical Research Institutes, Beirut, Lebanon.

Athanase Benetos (A)

c Université de Lorraine, Inserm, DCAC, F-54000 Nancy, France.
d Université de Lorraine, CHRU-Nancy, Pôle "Maladies du Vieillissement, Gérontologie et Soins Palliatifs", F-54000, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH